GC–MS profiling and computational analysis of Balanites aegyptiaca phytoconstituents for antidiabetic activity: insights from network pharmacology and molecular docking

Surendra Kumar Gautam, Rakesh Kumar Paul, Smita Jain, Vipin Kumar and Kaisar Raza

Naunyn-Schmiedeberg's Arch Pharmacol, 2025
DOI: 10.1007/s00210-025-04187-8

Multifaceted relationship between diabetes and kidney diseases: Beyond diabetes

Pasquale Esposito, Daniela Picciotto, Francesca Cappadona, Francesca Costigliolo, Elisa Russo, Lucia Macciò and Francesca Viazzi

World J Diabetes, 2023, 14, 1450
DOI: 10.4239/wjd.v14.i10.1450

Biological Activities of Secondary Metabolites from the Edible-Medicinal Macrofungi

Xiaoqi Sun, Ying Shi, Dongxiao Shi, Yu Tu and Ling Liu

JoF, 2024, 10, 144
DOI: 10.3390/jof10020144

Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options

Teresa Salvatore, Raffaele Galiero, Alfredo Caturano, Erica Vetrano, Giuseppe Loffredo, Luca Rinaldi, Christian Catalini, Klodian Gjeloshi, Gaetana Albanese, Anna Di Martino, Giovanni Docimo, Celestino Sardu, Raffaele Marfella and Ferdinando Carlo Sasso

Biomedicines, 2022, 10, 2274
DOI: 10.3390/biomedicines10092274

Anti-inflammatory role of SGLT2 inhibitors as part of their anti-atherosclerotic activity: Data from basic science and clinical trials

Lucia Scisciola, Vittoria Cataldo, Fatemeh Taktaz, Rosaria Anna Fontanella, Ada Pesapane, Puja Ghosh, Martina Franzese, Armando Puocci, Antonella De Angelis, Liberata Sportiello, Raffaele Marfella and Michelangela Barbieri

Front. Cardiovasc. Med., 2022, 9
DOI: 10.3389/fcvm.2022.1008922

Pleiotropic Effects of Sodium-Glucose Cotransporter-2 Inhibitors in Cardiovascular Disease and Chronic Kidney Disease

Anjay Rastogi and James Januzzi

JCM, 2023, 12, 2824
DOI: 10.3390/jcm12082824

SGLT2 Inhibitors: From Structure–Effect Relationship to Pharmacological Response

Teodora Mateoc, Andrei-Luca Dumitrascu, Corina Flangea, Daniela Puscasiu, Tania Vlad, Roxana Popescu, Cristina Marina and Daliborca-Cristina Vlad

IJMS, 2025, 26, 6937
DOI: 10.3390/ijms26146937

Modern trends in diuretics development

Tetiana Titko, Lina Perekhoda, Iryna Drapak and Yevgen Tsapko

European Journal of Medicinal Chemistry, 2020, 208, 112855
DOI: 10.1016/j.ejmech.2020.112855

Synthetic α-glucosidase inhibitors as promising anti-diabetic agents: Recent developments and future challenges

Alia Mushtaq, Uzma Azam, Saba Mehreen and Muhammad Moazzam Naseer

European Journal of Medicinal Chemistry, 2023, 249, 115119
DOI: 10.1016/j.ejmech.2023.115119

Recent developments in ligands and chemical probes targeting solute carrier transporters

Andrea Casiraghi, Ariel Bensimon and Giulio Superti-Furga

Current Opinion in Chemical Biology, 2021, 62, 53
DOI: 10.1016/j.cbpa.2021.01.012

Sodium-glucose transporter (SGLT2) inhibition: A potential target for treatment of type-2 Diabetes Mellitus with Natural and Synthetic compounds

Shubham Batra, Prabhjeet Kaur Bamrah and Manjusha Choudhary

Egyptian Journal of Basic and Applied Sciences, 2023, 10, 69
DOI: 10.1080/2314808X.2022.2145734

Ruthenium-Catalyzed Pyridine-Directed Aryl C–H Glycosylation with Glycosyl Chlorides

Shaokun Cai, Qikai Sun, Quanquan Wang, Gang He and Gong Chen

J. Org. Chem., 2022, 87, 8811
DOI: 10.1021/acs.joc.2c00815

Diabetes and Its Complications: Therapies Available, Anticipated and Aspired

Anu Grover, Komal Sharma, Suresh Gautam, Srishti Gautam, Monica Gulati and Sachin Kumar Singh

CDR, 2021, 17, 397
DOI: 10.2174/1573399816666201103144231

Effect of sodium-dependent glucose cotransporter type 2 inhibitors on lipid metabolism in patients with diabetes mellitus (literature review)

Nataliia Levchuk, Olena Kovzun, Volodymyr Pushkarev and Mykola Tronko

Journal NAMSU, 2023, 29, 5
DOI: 10.37621/JNAMSU-2023-1-2-1

SGLT2 inhibitors, an Accomplished Development in Field of Medicinal Chemistry: an Extensive Review

Anirudh Manoj, Subham Das, Anu Kunnath Ramachandran, Angel T Alex and Alex Joseph

Future Med. Chem., 2020, 12, 1961
DOI: 10.4155/fmc-2020-0154

Exogenous Ketones in Cardiovascular Disease and Diabetes: From Bench to Bedside

Urna Kansakar, Crystal Nieves Garcia, Gaetano Santulli, Jessica Gambardella, Pasquale Mone, Stanislovas S. Jankauskas and Angela Lombardi

JCM, 2024, 13, 7391
DOI: 10.3390/jcm13237391

Discovery of Orally Bioavailable FmlH Lectin Antagonists as Treatment for Urinary Tract Infections

Amarendar Reddy Maddirala, Kevin Tamadonfar, Jerome S. Pinkner, Denise Sanick, Scott J. Hultgren and James W. Janetka

J. Med. Chem., 2024, 67, 3668
DOI: 10.1021/acs.jmedchem.3c02128

Sodium-Glucose Cotransporter Inhibitors as Antidiabetic Drugs: Current Development and Future Perspectives

Rosanna Maccari and Rosaria Ottanà

J. Med. Chem., 2022, 65, 10848
DOI: 10.1021/acs.jmedchem.2c00867

Identification of novel small molecule inhibitors for solute carrier SGLT1; a computational exploration

Sajjad Haider, Mamona Mushtaq, Mohammad Nur-e-Alam, Aftab Ahmed and Zaheer Ul-Haq

Journal of Biomolecular Structure and Dynamics, 2024, 42, 12537
DOI: 10.1080/07391102.2023.2270708

Structure based virtual screening of natural compounds and molecular dynamics simulation: Butirosin as Dipeptidyl peptidase (DPP-IV) inhibitor

Rakesh Kumar Paul, Virendra Nath and Vipin Kumar

Biocatalysis and Agricultural Biotechnology, 2021, 35, 102042
DOI: 10.1016/j.bcab.2021.102042

Identification of behenic acid as medicinal food for the diabetes mellitus: structure-based computational approach and molecular dynamics simulation studies

Virendra Nath, Rakesh Kumar Paul, Neeraj Kumar and Vipin Kumar

J Mol Model, 2022, 28
DOI: 10.1007/s00894-022-05060-8

Imidazo[1,2-c]quinazolines as a novel and potent scaffold of α-glucosidase inhibitors: design, synthesis, biological evaluations, and in silico studies

Fariba Peytam, Faezeh sadat Hosseini, Malak Hekmati, Bahareh Bayati, Mahdis Sadeghi Moghadam, Zahra Emamgholipour, Loghman Firoozpour, Somayeh Mojtabavi, Mohammad Ali Faramarzi, Seyed Esmaeil Sadat-Ebrahimi, Maliheh Barazandeh Tehrani and Alireza Foroumadi

Sci Rep, 2023, 13
DOI: 10.1038/s41598-023-42549-5

Navigating the therapeutic landscape of SGLT2 inhibitors in diabetes management: exploring efficacy and emerging concerns

Hoda Farazul, Negi Harsha, Saini Digvijaya, Arshad Mawrah, Zayed Sidra, Raut Mukesh Kumar, Habib Mohammad Anwar, Akhtar Mohd and Najmi Abul Kalam

Exploration of Medicine, 2024
DOI: 10.37349/emed.2024.00255

Diastereoselective Pd-Catalyzed Anomeric C(sp3)–H Activation: Synthesis of α-(Hetero)aryl C-Glycosides

Juba Ghouilem, Christine Tran, Nicolas Grimblat, Pascal Retailleau, Mouad Alami, Vincent Gandon and Samir Messaoudi

ACS Catal., 2021, 11, 1818
DOI: 10.1021/acscatal.0c05052

In vitro and in vivo antidiabetic evaluation of new Coumarin and Chromone derivatives: Design, synthesis and molecular modeling

Aya M. Serry, Omaima M. Abdelhafez, Wagdy K.B. Khalil, Karima A. Hamed, Mohamed I. Mabrouk, Mohamed B. Shalaby and Eman Y. Ahmed

Bioorganic Chemistry, 2025, 159, 108338
DOI: 10.1016/j.bioorg.2025.108338